{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T04:10:31Z","timestamp":1744863031966,"version":"3.40.4"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,16]]},"DOI":"10.7759\/cureus.82366","type":"journal-article","created":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T13:25:01Z","timestamp":1744809901000},"source":"Crossref","is-referenced-by-count":0,"title":["Therapeutic Efficacy of 2% Mupirocin in Managing Staphylococcus aureus and Streptococcus pyogenes Wound Infections"],"prefix":"10.7759","author":[{"given":"Paola","family":"Rivera","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc B","family":"Bello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geraldo","family":"Brito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriela","family":"Pichardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elias","family":"Cruz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisy","family":"Blanco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmclc.2021.06.004","article-title":"[Managing adult skin infections]","volume":"32","author":"Flores R","year":"2021","unstructured":"Flores R, Villarroel JL, Valenzuela F. [Managing adult skin infections]. Rev Med Clin Las Condes. 2021, 32:429-41. 10.1016\/j.rmclc.2021.06.004","journal-title":"Rev Med Clin Las Condes"},{"key":"ref2","article-title":"[Formulations for wound healing: present and future]","volume":"2","author":"Laseca-Arranz A","year":"2021","unstructured":"Laseca-Arranz A, S\u00e1nchez-Dengra B, Bermejo-Sanz M, Gonz\u00e1lez-\u00c1lvarez I, Gonz\u00e1lez-\u00c1lvarez M. [Formulations for wound healing: present and future]. Rev Esp Cien Farm. 2021, 2:1-12.","journal-title":"Rev Esp Cien Farm"},{"key":"ref3","article-title":"Basic principles of wound healing","author":"Armstrong DG","year":"2024","unstructured":"Armstrong DG, Meyr AJ. Basic principles of wound healing. UpToDate. Berman RS, Eidt JF, Mills JL Sr, Collins KA (ed): Wolters Kluwer, Philadelphia, PA; 2024."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.862112","article-title":"Mupirocin promotes wound healing by stimulating growth factor production and proliferation of human keratinocytes","volume":"13","author":"Twilley D","year":"2022","unstructured":"Twilley D, Reva O, Meyer D, Lall N. Mupirocin promotes wound healing by stimulating growth factor production and proliferation of human keratinocytes. Front Pharmacol. 2022, 13:862112. 10.3389\/fphar.2022.862112","journal-title":"Front Pharmacol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3390\/futurepharmacol1010007","article-title":"Recent advances in mupirocin delivery strategies for the treatment of bacterial skin and soft tissue infection","volume":"1","author":"Gangwar A","year":"2021","unstructured":"Gangwar A, Kumar P, Singh R, Kush P. Recent advances in mupirocin delivery strategies for the treatment of bacterial skin and soft tissue infection. Future Pharmacol. 2021, 1:80-103. 10.3390\/futurepharmacol1010007","journal-title":"Future Pharmacol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.37551\/52254-28842022034","article-title":"[Analysis of the mupirocin application in the healthy exit site in peritoneal dialysis]","volume":"25","author":"Fern\u00e1ndez-P\u00e9rez M","year":"2022","unstructured":"Fern\u00e1ndez-P\u00e9rez M, Su\u00e1rez-\u00c1lvarez A, Men\u00e9ndez-Servide F, Blanco-Sierra J, Pasar\u00f3n-Alonso M, N\u00fa\u00f1ez-Moral M. [Analysis of the mupirocin application in the healthy exit site in peritoneal dialysis]. Enferm Nefrol. 2022, 25:337-42. 10.37551\/52254-28842022034","journal-title":"Enferm Nefrol"},{"key":"ref7","article-title":"Mupirocin","author":"Erwin DZ","year":"2024","unstructured":"Erwin DZ, Chen P. Mupirocin. StatPearls Publishing, Treasure Island, FL; 2024."},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.17533\/udea.iatreia.71","article-title":"[High sensitivity to mupirocin in Staphylococcus aureus isolates colonizing hemodialysis patients in a renal unit in Medell\u00edn, Colombia]","volume":"34","author":"Torres-Cuadros YL","year":"2021","unstructured":"Torres-Cuadros YL, V\u00e9lez-Montoya JG, Vanegas-M\u00fanera JM, Roncancio-Villamil GE, Jim\u00e9nez-Quiceno JN. [High sensitivity to mupirocin in Staphylococcus aureus isolates colonizing hemodialysis patients in a renal unit in Medell\u00edn, Colombia]. Iatreia [Internet]. 2021, 34:97-106. 10.17533\/udea.iatreia.71","journal-title":"Iatreia [Internet]"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/339621-therapeutic-efficacy-of-2-mupirocin-in-managing-staphylococcus-aureus-and-streptococcus-pyogenes-wound-infections","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T13:25:02Z","timestamp":1744809902000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/339621-therapeutic-efficacy-of-2-mupirocin-in-managing-staphylococcus-aureus-and-streptococcus-pyogenes-wound-infections"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,16]]},"references-count":8,"URL":"https:\/\/doi.org\/10.7759\/cureus.82366","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4,16]]}}}